Preoperative chemoradiation with capecitabine and cetuximab within a multidisciplinary therapeutic approach in patients with operable T4 rectal cancer: a phase II study.
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2015
At a glance
- Drugs Capecitabine (Primary) ; Cetuximab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 07 Dec 2015 New source identified and integrated as European Clinical Trials Database (EudraCT2005-003740-62).
- 29 Dec 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.